Showing results (111-120 of 189) with videos related to
Sort By:
Pageof 19
The Journal of Biological Chemistry|July 15, 1993
The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzymeK Keyomarsi, J Samet, G Molnar, et al.Cancer Research|October 23, 1997
Re-expression of elafin in 21MT2 breast carcinomas by phorbol 12-myristate 13-acetate is mediated by the Ap1 site in the elafin promoterM Zhang, D Magit, A B Pardee, et al.Cancer Research|July 1, 1991
Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatinK Keyomarsi, L Sandoval, V Band, et al.Cancer Research|February 1, 1989
Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase ID A Boothman, D K Trask, A B PardeeProceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Cell-cycle-specific interaction of nuclear DNA-binding proteins with a CCAAT sequence from the human thymidine kinase geneG B Knight, J M Gudas, A B PardeeProceedings of the National Academy of Sciences of the United States of America|August 1, 1979
Loss of epidermal growth factor requirement and malignant transformationP V Cherington, B L Smith, A B PardeeDevelopment (Cambridge, England)|August 24, 1999
Sprouty is a general inhibitor of receptor tyrosine kinase signalingA Reich, A Sapir, B ShiloNucleic Acids Research|August 25, 1995
Quantification of DNA-protein interaction by UV crosslinkingG Molnar, N O'Leary, A B Pardee, et al.Molecular Medicine (Cambridge, Mass.)|July 28, 2001
Potent induction of apoptosis by beta-lapachone in human multiple myeloma cell lines and patient cellsY Li, C J Li, D Yu, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|May 1, 1993
Posttranscriptional control of thymidine kinase messenger RNA accumulation in cells released from G0-G1 phase blocksJ M Gudas, J L Fridovich-Keil, A B PardeePageof 19